- Home
- NC vs CRDF Comparison
NC vs CRDF Comparison
Compare NC & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NC
- CRDF
- Stock Information
- Founded
- NC 1913
- CRDF 1999
- Country
- NC United States
- CRDF United States
- Employees
- NC N/A
- CRDF N/A
- Industry
- NC Coal Mining
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NC Energy
- CRDF Health Care
- Exchange
- NC Nasdaq
- CRDF Nasdaq
- Market Cap
- NC 315.7M
- CRDF 233.5M
- IPO Year
- NC N/A
- CRDF N/A
- Fundamental
- Price
- NC $39.32
- CRDF $2.49
- Analyst Decision
- NC
- CRDF Strong Buy
- Analyst Count
- NC 0
- CRDF 6
- Target Price
- NC N/A
- CRDF $11.92
- AVG Volume (30 Days)
- NC 6.3K
- CRDF 2.5M
- Earning Date
- NC 08-06-2025
- CRDF 07-29-2025
- Dividend Yield
- NC 2.25%
- CRDF N/A
- EPS Growth
- NC N/A
- CRDF N/A
- EPS
- NC 4.61
- CRDF N/A
- Revenue
- NC $249,990,000.00
- CRDF $545,000.00
- Revenue This Year
- NC N/A
- CRDF N/A
- Revenue Next Year
- NC N/A
- CRDF N/A
- P/E Ratio
- NC $8.69
- CRDF N/A
- Revenue Growth
- NC 14.71
- CRDF N/A
- 52 Week Low
- NC $25.19
- CRDF $2.01
- 52 Week High
- NC $45.50
- CRDF $5.64
- Technical
- Relative Strength Index (RSI)
- NC 46.57
- CRDF 29.80
- Support Level
- NC $39.73
- CRDF $3.73
- Resistance Level
- NC $41.50
- CRDF $4.52
- Average True Range (ATR)
- NC 1.17
- CRDF 0.35
- MACD
- NC -0.19
- CRDF -0.17
- Stochastic Oscillator
- NC 25.60
- CRDF 6.76
About NC NACCO Industries Inc.
NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.